| INTRODUCTION
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterised by inflammation and progressive fibrosis of the intra-and/or extrahepatic bile ducts. PSC affects predominantly younger men and is frequently associated with a distinct form of colitis. 1 To date, there is no effective therapy for PSC, and the disease progresses to biliary cirrhosis within 10-20 years in most patients. 2 PSC is one of the leading indications for liver transplantation in Northern Europe and the USA. 3, 4 One of the major clinical challenges in PSC is the early detection of disease related complications, most importantly biliary malignancies and functionally relevant biliary strictures. Cholangiocarcinoma (CCA)
develops in approximately 15%-20% of patients and is regarded as the leading cause of death in PSC. [5] [6] [7] Most commonly, CCA presents as a stricture of the bile duct and less often as a mass lesion. 6 Dominant bile duct strictures develop in more than 50% of PSC patients over time and in it seem to be a risk factor for the development of CCA. 6 Screening patients for novel or worsening biliary strictures, therefore, appears reasonable. 8 Magnetic resonance imaging (MRI) with magnetic resonance cholangiopancreatography (MRCP) has developed into the standard imaging modality to diagnose PSC and appears to be useful for the detection of bile duct and parenchymal changes associated with disease progression as well as the diagnosis of PSC associated CCA. 8, 9 Albeit the clinical perceptions of biliary strictures may vary across practitioners and institutions, 10 it is recommended that novel or worsening bile duct strictures should be further assessed using endoscopic retrograde cholangiopancreatography (ERCP) with tissue sampling to exclude CCA. 9 Therefore, most large volume centres perform follow-up MRI/MRCP in their PSC patients. 6, 7, [11] [12] [13] [14] [15] Retrospective data recently published by Ali et al support the notion that surveillance of hepatobiliary cancer may significantly improve outcome in PSC. 16 Prospective data on CCA surveillance and its impact on the detection of early stage cancer and on patient survival are, however, lacking. As a consequence, recommendations on the use of MRI for CCA surveillance vary between current guidelines. 3, 4, 17, 18 Recently, the International PSC Study Group (IPSCSG) recommended that the use of MRI for surveillance of CCA in PSC should be an individualised decision. We hypothesised that in PSC the interpretation of follow-up MRI/MRCP and subsequent treatment recommendations, particularly with respect to the indication to perform ERCP, may significantly vary even across PSC-experienced clinicians. We therefore con- Figure S1 .
Each of these 16 PSC cases was followed by a multiple-choice questionnaire. This questionnaire assessed the survey participant 0 s overall MRI/3D-MRCP interpretation (1), the presence of bile duct changes (2), the presence of dominant strictures (3), the presence of CCA (4), whether ERCP should be performed (5) and arguments for/ against ERCP recommendation (6) . Possible answers are provided in Table 1 .
Survey participants were recruited within the IPSCSG and associates and were primarily specialised in gastroenterology (including five participants primarily specialised in endoscopy), hepatology or radiology. A participation in the survey was possible between March and June 2016 in an anonymous fashion. Since completing the survey was associated with a significant amount of time (60-90 min), survey participants were invited to email their personal data after finishing the survey to be acknowledged by banner-co-authorship (Appendix 1).
| Statistical analysis
Only results from participants, who completed the survey, went into the final analysis. Survey participants 0 characteristics ( ZENOUZI ET AL.
| 171 described using the median value accompanied by the first (Q1) and the third quartile (Q3). To assess the agreement with respect to the MRI/3D-MRCP interpretation within the cohort of survey participants an inter-rater reliability calculation was performed using the Fleiss 0 kappa value. To assess the systematic influence of case and respondent related variables on the respondent ratings we additionally applied generalised linear mixed effects models (GLMM) controlling for the individual raters and cases as random factors. We aimed to assess the fixed effects influencing the respondents 0 votes on: the presence of dominant strictures, the presence of CCA and the indication for ERCP. As fixed effects the following independent variables were considered for each of the above listed dependent variables:
the presence of liver cirrhosis, symptoms, signs of cholangitis (defined by elevated white blood cell count or C-reactive protein plus symptoms), bilirubin level (normal or elevated; upper limit of normal: 1.1 mg/dL) and the specialisation of the respective respondent. The latter was split in dichotomous dummy variables: gastroenterologist, hepatologist and radiologist. First, we explored unconditional models by assessing the association of each independent variable with the respective outcomes by univariate GLMM analyses. Variables that retained a P < 0.05 were intended to be included in multivariate GLMM. The potential interference between predictor variables was tested post-hoc by Chi-squared test or Fisher's exact test (where appropriate) to guarantee the model assumption of independent predictors. In case of a significant relationship, the independent variable displaying a higher P-value and higher
Overall MRI/3D-MRCP interpretation Akaike information criterion was dropped. This model building approach has been described previously. 19, 20 For the GLMM Laplace approximation, a logit link was used as provided in the "glmer function" of the "lme4" R package. 21 All statistical analyses were performed with the R statistical programming language version 3.4.1 (R Foundation for Statistical Computing, Vienna, Austria).
As all provided data in the survey were based on real-life cases follow-up data were available, enabling a comparison of the survey Figure 1D ) (Κ = 0.13, 95%
CI 0.11-0.15). The lowest kappa value was found with regard to the recommendation whether subsequently ERCP should be performed ( Figure 1E ), which was consistent among more than 75% of the participants in only 4/16 cases (Κ = 0.12, 95% CI 0.11-0.14).
| Assessment of variables associated with recommendation for/against ERCP
To assess the rationale behind the survey participants 0 decision to recommend for or against subsequent ERCP, a multiple-choice questionnaire was used. As multiple answers were possible, the total number of votes below exceeds the number of survey participants (n = 44) multiplied with the number of cases (n = 16).
If ERCP was recommended (n = 398), this was predominantly to "obtain brush cytology/histology" (n = 349) followed by dilatation of strictures, including "balloon/bougie dilatation" (n = 264) and "stent placement" (n = 175). Less frequent arguments for ERCP recommendation were "to obtain bile for microbial culture" (n = 104) and "for diagnostic purpose only" (n = 17).
If ERCP was not recommended (n = 306), the survey participants most frequently quoted that the "risk of ERCP outweighs the potential benefit" (n = 242). Less frequently selected arguments were "too many strictures" (n = 46), a "too advanced disease" (n = 22) or that "ERCP is generally not appropriate for PSC treatment" (n = 22) (Figure 2 ).
| Influence of case-/rater-related factors on MRI/3D-MRCP interpretation and subsequent ERCP recommendation
The main outcome of follow-up MRI in PSC should be to identify novel or worsening dominant strictures, to suspect CCA which should then prompt ERCP and tissue sampling or to decide upon endoscopic dilation treatment. To identify potential factors influencing the survey participants 0 decisions GLMM using a univariate GLMM as a first step were applied.
| Suspicion of dominant strictures
The univariate analysis revealed no associations between symptoms, signs of cholangitis or the rater 0 s specialisation and the frequency of suspecting dominant strictures. Presence of liver cirrhosis or elevated total bilirubin levels, however, were associated with suspecting dominant strictures. Due to the strong relationship between elevation of total bilirubin and liver cirrhosis (Chi-squared test, P < 0.01), it seems reasonable that total bilirubin as the factor with the strongest effect was responsible for that association (odds ratio 3.7, 95% CI 1.6-8.6, P < 0.01). Nevertheless, reassessing the impact of the factor liver cirrhosis while additionally controlling for total bilirubin as a random effect revealed that liver cirrhosis still was associated with a significantly higher rate of suspected dominant strictures (odds ratio 2.8 95% CI 1.1-7.6, P = 0.02; Table 3 ). Analysing factors that may trigger the suspicion of CCA, significantly higher rates were only found in patients with elevated levels of total bilirubin (odds ratio 5.2, 95% CI 2.5-11.4, P < 0.01). Symptoms, signs of cholangitis, liver cirrhosis or the raters 0 specialisation did not seem to significantly impact on the frequency of CCA suspicion (Table 3) .
| ERCP recommendation
There are several accepted indications for ERCP in patients with PSC, among them signs of bacterial cholangitis with strictures or otherwise symptomatic disease with strictures amenable to treatment. In this survey, ERCP was more frequently recommended only in patients with signs of cholangitis or elevated total bilirubin. Due to the strong relationship between elevated total bilirubin and signs of cholangitis (Chi-squared test, P < 0.01), only total bilirubin, as the factor with the strongest effect, was considered significant (odds ratio 6.4, 95% CI 2.9-15.1, P < 0.01). Controlling for total bilirubin as a random effect no longer showed a significant influence of the factor cholangitis on the rate of ERCP recommendations (Table 3) .
There is a paucity of data on the role of ERCP in PSC with established cirrhosis and the recent ESGE (European Society of Gastrointestinal Endoscopy)/EASL (European Association for the Study of the Liver) guideline cautions on the use of ERCP in this population. 22 Interestingly, in this study presence of cirrhosis did not prevent raters to recommend ERCP after reviewing the MRI scans. 
| DISCUSSION
MRI/MRCP has been established as the imaging modality of choice in patients with suspected PSC. In addition, MRI/MRCP is used for surveillance purposes by many centres, 3, 6, 7, [11] [12] [13] 15, 17 although prospective data demonstrating benefit on the early detection of CCA or patient survival is lacking. Univariate GLMM were used to analyse potential factors associated with a higher rate of suspected dominant strictures, cholangiocarcinoma or ERCP recommendations. In case of significant results in more than one evaluated factor and an interference between these factors (evaluated with a post-hoc test), only the factor with the strongest level of significance was considered meaningful. ERCP, endoscopic retrograde cholangiopancreatography; MRCP, magnetic resonance cholangiopancreatography; MRI, magnetic resonance imaging. The values in bold are significant results with P < 0.05 a Nevertheless, reassessing the impact of the factor liver cirrhosis on the rate of suspected dominant strictures while additionally controlling for total bilirubin as a random effect revealed that liver cirrhosis still was associated with a significantly higher rate of suspected dominant strictures. Contrary, reassessing the impact of the factor cholangitis on the rate of ERCP recommendations while additionally controlling for total bilirubin levels revealed that cholangitis was no longer significantly associated with a higher rate of ERCP recommendations. For details, please see Section 2.
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| 175 participants gave advanced disease as an argument against ERCP (Figure 2 ). This contrasts the recent practice guideline of ESGE/ EASLE on the use of ERCP in PSC, which cautions against the use of ERCP in PSC cirrhosis. 9 In our study, the survey participants 0 recommendations with respect to ERCP performance contrasted the real-life clinical course.
Particularly, the overwhelming recommendation to perform ERCP in patients, who in real life did not seem to benefit from ERCP or were not affected by biliary complications during follow-up despite not undergoing ERCP underline the difficulty in interpretation of obtained images. These findings should, however, be interpreted with great caution, since a reasonable definition of a "beneficial"
ERCP was not possible due to our study design.
In our study, the survey participants 0 recommendations with respect to ERCP performance contrasted the real-life management and outcome. Particularly, the overwhelming recommendation to perform ERCP in patients, who in real-life did not seem to benefit from ERCP or were not affected by biliary complications during follow-up despite not undergoing ERCP, underline the difficulty in interpretation of obtained images. These findings should, however, be interpreted with great caution, since an evidence based definition of a "beneficial" ERCP cannot be applied.
In the recent ESGE/EASL practice guideline on endoscopy in PSC, ERCP is recommended in patients with established PSC with relevant or aggravating symptoms, new or progressive dominant strictures or with a rapid increase in cholestatic enzyme levels. 9 However, the quality of evidence underlying these recommendations is low and a MRI-based definition of dominant strictures is lacking.
Originally, the term "dominant stricture" derives from ERCP studies and defines strictures in the common bile duct of less than 1.5 mm and in the left or right or common hepatic duct of less than 1 mm. 24 Nevertheless, from our experience, the term "dominant stricture" is widely used by clinicians for MRI reporting as well, and is indeed part of liver transplantation listing criteria in some countries, independent from the diagnostic technique applied. 25 Considering this and the lack of agreement among the survey participants in this study, we suggest that the term dominant stricture should not be 
